Spero Therapeutics (SPRO) Selling, General & Administrative (2016 - 2026)
Spero Therapeutics' Selling, General & Administrative came in at $6.49 million for Q2 2026, up 10.4% from $5.88 million a year earlier and up 32.8% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Selling, General & Administrative (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Spero Therapeutics reported Selling, General & Administrative of $19.85 million, down 20.4% year-over-year; for FY2025, it was $21.18 million, down 10.7% from FY2024.
- Selling, General & Administrative has declined in each of the last four years, with a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $23.7 million in FY2024 (-7.2%), $25.55 million in FY2023 (-30.0%), $36.48 million in FY2022 (-12.5%) and $41.7 million in FY2021 (+94.5%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q1 2025.
- Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with an average decline of 6.8%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 110.1%), and the weakest in Q1 2023 (a decline of 52.2%).
- Business Quant data shows SPRO's Selling, General & Administrative at $4.89 million (Q1 2026), $4.3 million (Q4 2025) and $4.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.40 Bn | 1,112.99 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 634.88 Bn | 554.74 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 500.40 Bn | 473.51 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.05 Bn | 310.43 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 301.50 Bn | 265.49 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 264.72 Bn | 238.40 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.19 Bn | 169.39 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Spero Therapeutics | 64.92 Mn | -130.86 Mn | - | 6.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.49 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 6.82 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 5.92 Mn |
| Dec 31, 2023 | 6.43 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 6.10 Mn |
| Mar 31, 2023 | 7.32 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Sep 30, 2022 | 6.63 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 15.31 Mn |
| Dec 31, 2021 | 13.02 Mn |
| Sep 30, 2021 | 11.15 Mn |
API Access
Spero Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();